CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,000 | -69.9% | 19,200 | -63.7% | 0.00% | -100.0% |
| Q4 2021 | $146,000 | -69.6% | 52,947 | -33.8% | 0.00% | -83.3% |
| Q3 2021 | $480,000 | +269.2% | 79,967 | +200.0% | 0.01% | +500.0% |
| Q2 2021 | $130,000 | +154.9% | 26,656 | +29.4% | 0.00% | 0.0% |
| Q1 2021 | $51,000 | -3.8% | 20,600 | +139.6% | 0.00% | -66.7% |
| Q3 2018 | $53,000 | +1225.0% | 8,599 | +2049.8% | 0.00% | – |
| Q2 2018 | $4,000 | -97.0% | 400 | -96.7% | 0.00% | -100.0% |
| Q1 2018 | $132,000 | – | 12,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |